# MDHC

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mdhc

- Industry: Medical Devices & Equipment
- Headquarters: Kunshan, China
- Website: www.mdhc-bio.com
- Latest round: Series C (Dec 12, 2024)
- Investors on record: 1

## About

Based in Suzhou, China, and established in 2021, MDHC is a medical equipment company that lab automation equipment and biology trial consumables. It has four production bases, and a total area covering 10,000 square meters, including 8,000 square meters of injection and molding manufacturing plant. And it received multiple product certifications, including NQA ISO 13485, CE, and FDA. In January 2023, the company closed strategic investment led by new investor Lucion Venture Capital. In December 2024, the firm closed a series C++ funding.

MDHC's products can be categorized as automatic instruments, robotic tip series, universal pipette tip series, PCR series, nucleic acid extraction series, nucleic acid sampling set series, centrifuge tube series, cryogenic tube series, serological pipette series, and cell culture series. The automatic instruments include automation sample processing systems and sample transfer processing systems. Universal pipette tip series includes 10 microliters (uL), 20uL, 30uL, 100uL, 300uL, 500uL, and 1000uL. The centrifuge tube series include 0.6 milliliters (mL), 1.5mL, 2mL, 15mL, and 50mL.

The company generates revenue by providing laboratory automation equipment and consumables.

The company will use the series C++ funding for the development and operation of its consumer healthcare and life sciences storage pipeline.

## Funding rounds

- Series C, Dec 12, 2024 — Funway Capital

## Investors

- Funway Capital (https://capitalatlas.ai/funds/funway-capital) — Series C